Page last updated: 2024-09-05

deferasirox and rolapitant

deferasirox has been researched along with rolapitant in 1 studies

Compound Research Comparison

Studies
(deferasirox)
Trials
(deferasirox)
Recent Studies (post-2010)
(deferasirox)
Studies
(rolapitant)
Trials
(rolapitant)
Recent Studies (post-2010) (rolapitant)
832136572511746

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bakr, AF; El-Sherbiny, IM; Kabil, MF; Mahmoud, MY; Zaafar, D1

Other Studies

1 other study(ies) available for deferasirox and rolapitant

ArticleYear
Switching indication of PEGylated lipid nanocapsules-loaded with rolapitant and deferasirox against breast cancer: Enhanced in-vitro and in-vivo cytotoxicity.
    Life sciences, 2022, Sep-15, Volume: 305

    Topics: Animals; Breast Neoplasms; Deferasirox; Female; Humans; Lipids; Mice; Nanocapsules; Neoplasm Recurrence, Local; Polyethylene Glycols; Spiro Compounds

2022